Form 4: Ingevity SVP Reports RSU Grant and Tax Withholdings
Insider Transaction Report
Ingevity's SVP of Operations, Clarence Reid Clontz Jr., reported the grant of 2,343 restricted stock units and subsequent sales to cover tax obligations from vested RSUs.
Summary
- Clarence Reid Clontz Jr., SVP, Operations at Ingevity Corp (NGVT), reported changes in his beneficial ownership of common stock.
- On February 27, 2026, Mr. Clontz was granted 2,343 restricted stock units (RSUs) under the Ingevity Corporation 2025 Omnibus Incentive Plan.
- These RSUs will vest in three equal installments on February 27, 2027, February 27, 2028, and February 27, 2029.
- On March 2, 2026, Mr. Clontz disposed of a total of 726 shares of common stock at a price of $71.64 per share.
- These disposals were shares withheld by the company to satisfy tax withholding obligations related to previously vested RSUs from 2023 (143 shares), 2024 (264 shares and 49 shares), and 2025 (270 shares).
- Following these transactions, Mr. Clontz's direct beneficial ownership of common stock is 8,980 shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. It represents routine executive compensation and tax-related transactions, which do not indicate a change in the company's operational or financial performance.
Positives
- The grant of 2,343 restricted stock units (RSUs) to a Senior Vice President aligns management's long-term interests with shareholder value creation.
Negatives
- The disposals of shares were solely for tax withholding purposes upon the vesting of prior RSU grants, not a discretionary sale by the insider.
Future Outlook
No forward-looking statements or guidance regarding company performance are provided in this insider transaction report.
Industry Context
StockSavvy.ai notes that the grant of restricted stock units and subsequent tax-related share withholdings are standard practices in executive compensation across various industries, designed to incentivize long-term performance and align management interests with shareholders.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of executive compensation is a common practice across publicly traded companies, including those in the specialty chemicals and materials sector where Ingevity operates.
- The structure of vesting over multiple years is typical for long-term incentive plans, similar to practices observed at peers like Ashland Global Holdings Inc. (ASH) or Kraton Corporation (KRA), prior to its acquisition.
Stakeholder Impact
- Shareholders: The RSU grant aligns the interests of a key executive with long-term shareholder value. The tax-related disposals are routine and have minimal impact on overall share float.
Next Steps
- The granted RSUs will vest in three equal installments on February 27, 2027, 2028, and 2029.
Key Dates
| Date | Description |
|---|---|
| 02/27/2026 | Grant of 2,343 restricted stock units (RSUs) to Clarence Reid Clontz Jr. |
| 03/02/2026 | Disposal of 726 shares of common stock to satisfy tax withholding obligations for vested 2023, 2024, and 2025 RSUs. |
| 03/03/2026 | Date of signature for the Form 4 filing. |
| 02/27/2027 | First installment vesting date for the 2,343 RSUs granted on 02/27/2026. |
| 02/27/2028 | Second installment vesting date for the 2,343 RSUs granted on 02/27/2026. |
| 02/27/2029 | Third installment vesting date for the 2,343 RSUs granted on 02/27/2026. |
Recommendation
holdThis Form 4 filing details routine executive compensation, specifically the grant of restricted stock units and subsequent tax-related share disposals. These transactions are standard and do not provide new information that would fundamentally alter the investment thesis for Ingevity. The RSU grant is a positive for management alignment, but the overall impact on the stock's valuation or future prospects is negligible, warranting a 'hold' recommendation based solely on this filing.
Keywords
Ingevity, NGVT, Form 4, Insider Transaction, Restricted Stock Units, RSU Grant, Executive Compensation, Stock Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.